Fluconazole and Rosuvastatin Interaction: Safety Assessment

Alternative Antifungal Options

The American Academy of Dermatology recommends terbinafine as the first-line treatment for onychomycosis (toenail fungus) due to its highest efficacy for dermatophyte infections and fewer drug interactions 1
Itraconazole can be considered as a second-line treatment, particularly for Candida infections, though it has its own contraindications in patients with heart failure 2
For systemic fungal infections, the Infectious Diseases Society of America recommends treatment selection based on the specific pathogen and infection site, with consideration of potential drug interactions 3, 4, 5

Consider alternative antifungal agents with lower potential for interaction with rosuvastatin, as recommended by the American College of Cardiology 1, 2
For onychomycosis specifically, the British Association of Dermatologists recommends considering topical antifungal treatments as an alternative when systemic therapy poses risks 6, 1

Higher doses of fluconazole (such as 450mg weekly) increase the risk of adverse effects and drug interactions, according to the American College of Clinical Pharmacy 1

Assess the necessity of antifungal therapy and confirm diagnosis with mycological examination, as recommended by the American Academy of Dermatology 1
If treatment is necessary, consider using a topical antifungal agent if appropriate for the infection, as recommended by the British Association of Dermatologists 6, 1
Select terbinafine instead of fluconazole if treating onychomycosis, as recommended by the American Academy of Dermatology 1